ΠΠ΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΠΏΡΠΈΡ ΠΈΠ°ΡΡΠΈΡ / Neurology and psychiatry
ΠΠΎΡΡΠΎΡΠ½Π½ΠΈ Π°Π΄ΡΠ΅ΡΠΈ Π½Π° ΡΠ°Π·ΠΈ ΠΊΠΎΠ»Π΅ΠΊΡΠΈΡ
Π‘ΠΏΠΈΡΠ°Π½ΠΈΠ΅ΡΠΎ Π²ΠΊΠ»ΡΡΠ²Π° ΠΎΡΠΈΠ³ΠΈΠ½Π°Π»Π½ΠΈ ΡΡΠ°ΡΠΈΠΈ ΠΈ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΠΈ ΠΎΠ±Π·ΠΎΡΠΈ ΠΎΡ Π²ΠΎΠ΄Π΅ΡΠΈ Π±ΡΠ»Π³Π°ΡΡΠΊΠΈ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΈ ΠΈ ΡΠ΅ΡΠ΅ΡΠ°ΡΠΈ Π½Π° ΡΡΠΆΠ΄Π΅ΡΡΡΠ°Π½Π½ΠΈ Π½Π°ΡΡΠ½ΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈ ΠΏΡΠ±Π»ΠΈΠΊΠ°ΡΠΈΠΈ Π² ΠΎΠ±Π»Π°ΡΡΡΠ° Π½Π° Π½Π΅ΡΠ²Π½ΠΈΡΠ΅ Π±ΠΎΠ»Π΅ΡΡΠΈ, ΠΏΡΠΈΡ
ΠΈΠ°ΡΡΠΈΡΡΠ°, Π²ΠΊΠ». Π΄Π΅ΡΡΠΊΠ° Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΠΏΡΠΈΡ
ΠΈΠ°ΡΡΠΈΡ, ΠΈ Π½Π΅Π²ΡΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΡΠ°.*****
ΠΠΎΠ΄ΠΈΡΠ½ΠΈΠ½Π° β Π₯LΠII/2012 *****
ISSN 1311-6584
ΠΡΠ΅Π³Π»Π΅ΠΆΠ΄Π°Π½Π΅
Π’ΡΡΡΠ΅Π½Π΅ ΠΠ΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΠΏΡΠΈΡ ΠΈΠ°ΡΡΠΈΡ / Neurology and psychiatry ΠΎΡ ΠΠ²ΡΠΎΡ "ΠΠ½Π³Π΅Π»Π΅ΡΠΊΠ°, Π. // Angeleska, E."
ΠΠΎΠΊΠ°Π·Π°Π½ΠΈ 1 - 1 ΠΎΡ 1
Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈ Π½Π° Π²ΡΡΠΊΠ° ΡΡΡΠ°Π½ΠΈΡΠ°
ΠΠΏΡΠΈΠΈ Π·Π° ΡΠΎΡΡΠΈΡΠ°Π½Π΅
- ΠΠΎΠΊΡΠΌΠ΅Π½ΡΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ ΠΡΡΠΈΡΠ°Π»ΠΎΠΏΡΠ°ΠΌ ΠΈ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠ° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ ΠΏΡΠΈ Π½Π΅ΠΎΠ½Π°ΡΠ°Π»Π΅Π½ LPS ΠΈΠ½Π΄ΡΡΠΈΡΠ°Π½ ΠΌΠΎΠ΄Π΅Π» Π½Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΡ ΠΏΡΠΈ ΠΏΠ»ΡΡ ΠΎΠ²Π΅ // Interactions between Escitalopram and physical activity in neonatal LPS-model of depression in rats(Π¦Π΅Π½ΡΡΠ°Π»Π½Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ° Π±ΠΈΠ±Π»ΠΈΠΎΡΠ΅ΠΊΠ°, ΠΠ£ Π‘ΠΎΡΠΈΡ // Central Medical Library, MU Sofia, 2017) Π₯Π°ΡΠΈΡΠΎΠ², Π. // Haritov, E.; ΠΠΎΡΠΈΠ»ΠΊΠΎΠ²Π°, Π. // Bosilkova, E.; Π Π°Π΄Π΅Π²Π°, Π. // Radeva, J.; ΠΠ½Π³Π΅Π»Π΅ΡΠΊΠ°, Π. // Angeleska, E.; ΠΠΎΡΠΈΡΠΎΠ²Π°, Π. // Borisova, L.; ΠΠΎΠ±ΡΠ΅Π²Π°, Π’. // Dobreva, T.Π Π΅Π·ΡΠΌΠ΅. ΠΠ°ΡΡΠ½ΠΈ Π΄Π°Π½Π½ΠΈ ΠΏΡΠ΅Π· ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΡΠ΅ Π³ΠΎΠ΄ΠΈΠ½ΠΈ Π΄ΠΎΠΊΠ°Π·Π²Π°Ρ, ΡΠ΅ Π½Π΅Π²ΡΠΎΠ²ΡΠ·ΠΏΠ°Π»Π΅Π½ΠΈΠ΅ΡΠΎ ΠΈΠΌΠ° ΠΊΠ»ΡΡΠΎΠ²Π° ΡΠΎΠ»Ρ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°ΡΠ° Π½Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΡΡΠ°. ΠΠ½Π°ΡΠΈΡΠ΅Π»Π΅Π½ ΠΏΡΠΎΡΠ΅Π½Ρ ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Ρ Π΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½ΠΈ ΡΠ°Π·ΡΡΡΠΎΠΉΡΡΠ²Π° Π½Π΅ ΠΏΠΎΡΡΠΈΠ³Π°Ρ Π·Π°Π΄ΠΎΠ²ΠΎΠ»ΠΈΡΠ΅Π»Π΅Π½ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅Π½ ΠΎΡΠ³ΠΎΠ²ΠΎΡ. ΠΠΈΠ΄Π½Π° Π΅ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎΡΡΡΠ° ΠΎΡ ΡΡΡΡΠ΅Π½Π΅ Π½Π° Π°Π»ΡΠ΅ΡΠ½Π°ΡΠΈΠ²Π½ΠΈ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ΠΈ Π² Π°Π½ΡΠΈΠ΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½Π°ΡΠ° ΡΠ΅ΡΠ°ΠΏΠΈΡ, ΠΊΠΎΡΡΠΎ Π΄Π° ΠΏΠΎΠ²Π»ΠΈΡΠ²Π° Π½Π΅Π²ΡΠΎΠ²ΡΠ·ΠΏΠ°Π»ΠΈΡΠ΅Π»Π½ΠΈΡΠ΅ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΈ, Π²ΡΠ²Π»Π΅ΡΠ΅Π½ΠΈ Ρ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°ΡΠ° Π½Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΡΡΠ°. Π£ΠΌΠ΅ΡΠ΅Π½Π°ΡΠ° ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠ° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ Π΅ ΠΎΠ±Π΅ΡΠ°Π²Π°ΡΠ° Π² ΡΠΎΠ·ΠΈ Π°ΡΠΏΠ΅ΠΊΡ, Π½ΠΎ Π½ΡΠΌΠ° ΠΏΡΠΎΡΡΠ²Π°Π½ΠΈΡ Π΄ΠΎΠΊΠΎΠ»ΠΊΠΎ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ½ΠΈΡΡ Ρ Π΅ΡΠ΅ΠΊΡ ΡΠ΅ Π΄ΡΠ»ΠΆΠΈ Π½Π° Π·Π°ΡΠΈΠ»Π²Π°Π½Π΅ Π½Π° ΡΡΡΠ°Π½ΠΎΠ²Π΅Π½ΠΈΡΠ΅ Π²Π΅ΡΠ΅ Π°Π½ΡΠΈΠΈΠ½ΡΠ»Π°ΠΌΠ°ΡΠΎΡΠ½ΠΈ Π΅ΡΠ΅ΠΊΡΠΈ Π½Π° ΠΌΠΎΠ΄Π΅ΡΠ½ΠΈΡΠ΅ Π°Π½ΡΠΈΠ΄Π΅ΠΏΡΠ΅ΡΠ°Π½ΡΠΈ. Π¦Π΅Π» Π½Π° Π½Π°ΡΡΠΎΡΡΠΎΡΠΎ ΠΏΡΠΎΡΡΠ²Π°Π½Π΅ Π΅ ΠΎΡΠ΅Π½ΠΊΠ° Π½Π° Π°Π½ΡΠΈΠ΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½ΠΈΡΠ΅ ΠΈ Π°Π½ΡΠΈΠΈΠ½ΡΠ»Π°ΠΌΠ°ΡΠΎΡΠ½ΠΈΡΠ΅ Π΅ΡΠ΅ΠΊΡΠΈ ΠΎΡ ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»Π½ΠΎΡΠΎ ΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠ°Π½ΠΎΡΠΎ ΠΏΡΠΈΠ»Π°Π³Π°Π½Π΅ Π½Π° ΠΡΡΠΈΡΠ°Π»ΠΎΠΏΡΠ°ΠΌ ΠΈ Ρ.Π½Π°Ρ. Π²ΡΡΡΡΡΠΎ ΡΠ΅ ΠΊΠΎΠ»Π΅Π»ΠΎ Π² ΠΈΠ½Π΄ΡΡΠΈΡΠ°Π½ Ρ Π»ΠΈΠΏΠΎΠΏΠΎΠ»ΠΈΠ·Π°Ρ Π°ΡΠΈΠ΄ (LPS) ΠΌΠΎΠ΄Π΅Π» Π½Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΡ ΠΏΡΠΈ ΠΏΠ»ΡΡ ΠΎΠ²Π΅, ΠΏΠΎΡΠΎΠ΄Π° ΠΠΈΡΡΠ°Ρ. Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈΡΠ΅ ΠΎΡ ΠΏΡΠΎΡΡΠ²Π°Π½Π΅ΡΠΎ ΠΏΠΎΠΊΠ°Π·Π²Π°Ρ, ΡΠ΅ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠ°Π½ΠΎΡΠΎ ΠΏΡΠΈΠ»Π°Π³Π°Π½Π΅ Π½Π° ΠΡΡΠΈΡΠ°Π»ΠΎΠΏΡΠ°ΠΌ ΠΈ Π²ΡΡΡΡΡΠΎ ΡΠ΅ ΠΊΠΎΠ»Π΅Π»ΠΎ Π²ΠΎΠ΄ΠΈ Π΄ΠΎ ΡΠΈΠ³Π½ΠΈΡΠΈΠΊΠ°Π½ΡΠ½ΠΎ Π½Π°ΠΉ-ΠΈΠ·ΡΠ°Π·Π΅Π½ Π΅ΡΠ΅ΠΊΡ Π²ΡΡΡ Ρ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈΡΠ΅ Π·Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½ΠΎΡΡ Π² ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΡΠ΅ΡΠΊΠΈΡΠ΅ ΡΠ΅ΡΡΠΎΠ²Π΅ (FST ΠΈ SPT), Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ ΡΡΡ ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»Π½ΠΎΡΠΎ ΠΈΠΌ ΠΏΡΠΈΠ»Π°Π³Π°Π½Π΅. ΠΡΠΎΠ±Π΅Π½ΠΎ Π²Π°ΠΆΠ½ΠΎ Π΅ ΡΠΈΠ»Π½ΠΎΡΠΎ ΡΠ΅Π΄ΡΡΠΈΡΠ°Π½Π΅ Π² Π½ΠΈΠ²Π°ΡΠ° Π½Π° ΠΏΡΠΎΠΈΠ½ΡΠ»Π°ΠΌΠ°ΡΠΎΡΠ½ΠΈΡ ΡΠΈΡΠΎΠΊΠΈΠ½ IL-1f3 Π² Ρ ΠΈΠΏΠΎΠΊΠ°ΠΌΠΏΡΡΠΈΡΠ΅ Π½Π° Π΅ΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»Π½ΠΈΡΠ΅ ΠΆΠΈΠ²ΠΎΡΠ½ΠΈ ΠΏΠΎΠ΄ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠ°Π½ΠΎΡΠΎ ΠΏΡΠΈΠ»Π°Π³Π°Π½Π΅ Π½Π° Π΄Π²Π°ΡΠ° ΠΏΠΎΠ΄Ρ ΠΎΠ΄Π°. Π’Π΅Π·ΠΈ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ Π΄Π°Π²Π°Ρ ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄Π° ΡΠ΅ ΡΠ²ΡΡΠ΄ΠΈ, ΡΠ΅ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠ°ΡΠ° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡ ΠΈ Π½ΡΠΊΠΎΠΈ ΠΎΡ ΡΡΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΈΡΠ΅ Π°Π½ΡΠΈΠ΄Π΅ΠΏΡΠ΅ΡΠ°Π½ΡΠΈ (SSRIs β se- lective serotonin reuptake inhibitors) Π΄Π΅ΠΉΡΡΠ²Π°Ρ ΡΠΈΠ½Π΅ΡΠ³ΠΈΡΠ½ΠΎ ΠΏΠΎ ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ Π½Π° Π΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½Π°ΡΠ° ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΡΠΈΠΊΠ° ΠΈ Π² ΠΎΡΠ½ΠΎΠ²Π°ΡΠ° Π½Π° ΡΠΎΠ²Π° Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΡΠ° ΡΠ΅Ρ Π½ΠΈΡΠ΅ ΠΈΠ΄Π΅Π½ΡΠΈΡΠ½ΠΈ Π΅ΡΠ΅ΠΊΡΠΈ Π½Π° ΡΠ΅Π΄ΡΡΠΈΡΠ°Π½Π΅ Π² Π½ΠΈΠ²Π°ΡΠ° Π½Π° Π½Π΅Π²ΡΠΎΠ²ΡΠ·ΠΏΠ°Π»Π΅Π½ΠΈΠ΅ΡΠΎ Π² Π¦ΠΠ‘, ΠΊΠΎΠΈΡΠΎ ΡΠ° ΡΠ²ΡΡΠ·Π°Π½ΠΈ Ρ Π΄Π΅ΠΏΡΠ΅ΡΠΈΠ²Π½ΠΎΡΠΎ ΡΠ°Π·ΡΡΡΠΎΠΉΡΡΠ²ΠΎ. // Abstract. Emerging evidence indicate that neuroinflammation may play a crucial role in the pathogenesis of depression. The increased prevalence of depressive disorders is due to suboptimal management. The current approach for treating depression includes different antidepressants, but they do not influence the underlying neuroinflammatory pathophysiology of depression. A significant percentage of patients not respond properly to currently available antidepressants. Obviously there is a major need to identify alternatives for treating depression and suppress the pathological neuroinflammation associated with depression. Moderate physical activity is promising in this aspect, but it is still unclear whether aerobic exercise could increase the therapeutic effect of modern antidepressants by reducing neuroinflammatory alterations in CNS. The aim of our study is to evaluate the antidepressant and antiinflammatory effects of combined application of physical activity and escitalopram in LPS-induced model of depression in Wistar rats. Depression was induced by administration on postnatal day 10 (PND 10) of LPS (50 Β΅g/kg, i.p.). After the weaning of rats at 21 PND, they received escitalopram (10 mg/kg) per os and had a free access to running wheel for 3 weeks. After the end of this period the animals were subject of forced swim test, sucrose preference test and were sacrificed in order to assess the levels of IL-1beta by ELISA in the hippocampus. The results of our study showed that combined application of escitalopram and running wheel produce significantly higher effect, compared to single application of both on immobility time in FST, sucrose consumption and importantly on the reduction of the level of IL-1beta in the hippocampus of rats. The present study provides novel evidence that physical activity act in a synergic manner with SSRIs in treating depression by suppressing the brain proinflammatory mileu. Our study provides strong evidence that by augmentation of antiinflammatory properties of SSRIs, physical activity is valuable tool for the treatment of therapeutic-resistant depression.